Dr. Elafros received the U-M Institute for Healthcare Policy & Innovation's (IHPI) Sandy-Hassmiller Early Career Health Services Research Award for her work "Identifying Provider-Level Barriers and Facilitators to the Diagnosis and Management of Peripheral Neuropathy."
Join Dr. Feldman for her celebratory lecture, who will be accompanied by President Santa Ono, Provost Laurie McCauley, Executive Vice President of Medical Affairs (EVPMA) Marschall Runge, and two other awardees.
Meet the physician-scientist who will divide his time between the neurology clinic and his own lab specializing in hereditary neuropathy.
Eva Feldman, M.D., Ph.D., shared with the BBC what we know about the causes of amyotrophic lateral sclerosis.
In its first two years, the Flint Neuropathy Study has already produced surprising results. An award from the NIH National Institute for Diabetes and Digestive and Kidney Diseases will allow the study to expand and delve further into the neuropathy problem in the under-resourced community, and identify how to fix it.
The international source for nutrition-related news wrote about research, recently published in Annals of Clinical and Translational Neurology that link diabetes to structural and functional changes in the brain.
Using MRI, Researchers found that both structural and functional changes in the brain were linked to diabetes. They also found that diabetes complications were also linked to these changes.
Eva Feldman, M.D., Ph.D., was named to a new National Academies of Science, Engineering, and Medicine (NASEM) committee whose goal is to "identify and recommend key actions for the public, private, and nonprofit sectors to undertake to make ALS a livable disease within a decade."
A collaboration effort between the NeuroNetwork and the University of Michigan's Biointerfaces Institute created a new method to artificially grow 'mini-brains' (without animal components) that has the potential to revolutionize translational neuroscience research.
For a three-year term, Dr. Feldman will serve on the National Academy of Medicine's (NAM) governing and oversight council with other healthcare luminaries.
Health Lab , the official blog of Michigan Medicine, covered a recent publication in Microbiome that found a connection between the species in your gut (affected by what you eat) and diabetic neuropathy.
In her first address as American Diabetes Association (ADA) President of Medicine & Science, Dr. Rodica Pop-Busui shared her journey in diabetes research. From her beginnings in Timisoara, Romania before coming to Michigan Medicine and becoming one of the top international clinician-scientists in the field of diabetes and it's complications
A large contingent from the NeuroNetwork lab joined fellow members from around the work for the Peripheral Nerve Society's Annual Meeting, held this year in Copenhagen, Denmark.
Michigan Medicine's Health Lab wrote about the study led by Stephen Goutmen, M.D., M.S., which was published in Neurology Genetics, that finds a newly created polygenic scoring system — one that weighs the combined effects of common genetic variants — can improve the ability to predict an individual’s risk of developing ALS.
Stephanie Eid, Ph.D., added to her growing accolades with the Peter J. Dyck Award for Diabetes Research by the Peripheral Nerve Society (PNS), one of the most prestigious international awards for early career researchers in the field of neuropathy.
Dr. Feldman was part of a multi-institutional team of top researchers that published findings in JAMA that evaluated academic medical culture, faculty mental health, and their relationship.
Melissa Elafros, M.D., Ph.D., is the primary investigator for "Establishing the Zambian Cohort of Healthy Aging and Dementia Partnership," which won one of four grants to "launch new meaningful research collaborations between UMMS (University of Michigan Medical School) faculty and counterparts abroad."
Dr. Feldman spoke about receiving the incredible honor of her career and shared how her time as chief resident shaped who she became.
